The evolving role of fluorodeoxyglucose positron emission tomography (FDG PET) in lymphoma: how do we reconcile conflicting results in the era of evidence-based medicine?
Hicks
Rodney J
RJ
Peter MacCallum Cancer Centre, Melbourne, VIC, 3002, Australia. Rod.Hicks@petermac.org
D019317:Evidence-Based Medicine; D019788:Fluorodeoxyglucose F18; D006801:Humans; D008223:Lymphoma / Q000175:diagnosis* / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals; D012107:Research Design
D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18